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In COPD, skeletal muscle ATP resynthesis may be insufficient to meet demand during exercise
due to excessive anaerobic and reduced oxidative (mitochondrial) energy production, leading
to metabolic stress. We investigated the effect of outpatient pulmonary rehabilitation (PR) on
the metabolic response (measured by exercise-induced accumulation of plasma ammonia) and
determined whether this response predicted functional improvement following PR.
25 subjects with stable COPD [mean (SD) age 67 (8)years and FEV1 47 (18)% predicted] per-
formed maximal cycling ergometry before and after PR. Plasma ammonia was measured at
rest, during exercise and 2 min post-exercise.
Following PR, there were significant increases in peak cycle WR and ISWT performance
(Mean (SEM) changes 13.1 (2.0) W and 93 (15) m respectively, p < 0.001). Mean (SEM) rise in
plasma ammonia was reduced at peak (Pre vs Post-PR: 29.0 (4.5) vs 20.2 (2.5) mmol/l,
p < 0.05) and isotime (Pre vs Post-PR: 29.0 (4.5) vs 10.6 (1.7) mmol/l, p < 0.001) exercise.
Improvements in exercise performance after PR were similar among subgroups who did versus
those who did not show a rise in ammonia at baseline.
The results suggest that muscle cellular energy production was better matched to the
demands of exercise following PR. We conclude that a pragmatic outpatient PR programme
involving high intensity walking exercise results in significant adaptation of the skeletal muscle
metabolic response with a reduction in exercise-related metabolic stress. However, the
outcome of PR could not be predicted from baseline metabolic response.
ª 2010 Elsevier Ltd. All rights reserved.62583450.
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Peripheral skeletal muscle dysfunction contributes to
exercise limitation in patients with COPD.1 Reduced
capacity for oxidative metabolism and excessive anaerobic
metabolism occurs during whole body exercise in COPD
despite the low absolute workloads these disabled individ-
uals can achieve.2,3 We have previously demonstrated in
COPD patients that this may lead to substantial skeletal
muscle adenine nucleotide loss because ATP (adenosine
triphosphate) production cannot meet demand.4 This situ-
ation has been termed “metabolic stress” and has been
identified as an important cause of fatigue during high
intensity exercise in healthy subjects.5
Ammonia is released from the skeletal muscles during
exercise as a result of the irreversible deamination of AMP
to form IMP.6 Plasma ammonia accumulation is therefore
a consequence of adenine nucleotide loss and metabolic
stress, and has potential as a biomarker for the skeletal
muscle energy response. We recently showed that blood
ammonia accumulation occurs during a single bout of high
intensity exercise in COPD patients and that this was
indicative of muscle adenine nucleotide loss.7 We have
demonstrated that ammonia accumulation occurs in COPD
during both walking and cycling exercise.8 In addition, we
have observed a subgroup of patients who did not exhibit
a rise in blood ammonia despite performing similar exercise
workloads.7,8 This might be important as the failure to
develop metabolic stress during exercise may influence
subsequent physiological adaptation to exercise training by
moderating the degree of muscle overload.
Pulmonary rehabilitation (PR) is an effective interven-
tion for improving exercise capacity and therefore reducing
disability in patients with COPD.9 Physiological adaptation
within the skeletal muscles has been demonstrated in
response to PR3,10 although the gains made depend on the
intensity of training.11 Moreover, the functional benefits
that accrue may also be due to behavioural effects such as
improving confidence and reducing fear of breathlessness.
Whilst this does not diminish the clinical benefits of the
intervention, a better understanding of the mechanisms
behind the muscle disease and response to PR might allow
the components of rehabilitation programmes to be better
tailored to individual needs and physiology. For example,
pharmacological or nutritional augmentation of rehabilita-
tion would be likely to be more effective in those who
demonstrate physiological adaptation.
In this study we aimed to observe prospectively the
impact of a pragmatic, semi-supervised walking based
outpatient pulmonary rehabilitation programme on the
pattern and magnitude of the blood ammonia response to
whole body exercise. We hypothesized that rehabilitation
would reduce the degree of metabolic stress as measured
by blood ammonia accumulation. Our second aim was to
determine whether this measure of exercise-induced
metabolic stress at baseline predicted the physiological and
functional outcome of rehabilitation. We hypothesized that
patients not eliciting an ammonia response to exercise
would respond less well to pulmonary rehabilitation
because of reduced muscle overload in these individuals
and therefore adaptation to training would be attenuated.Methods
Patients referred to the outpatient pulmonary rehabilita-
tion (PR) programme at Glenfield Hospital who met GOLD
clinical and spirometric criteria for COPD12 were consecu-
tively assessed for inclusion in the study. Referral sources
were both secondary care specialist respiratory clinics and
primary care. Participant’s clinical condition and medical
therapy were stable prior to commencing PR. Patients were
excluded from the programme if considered unsuitable for
the exercise component due to musculoskeletal impair-
ment, significant medical conditions such as unstable
coronary artery disease or when compliance with PR was
not possible. Additional study exclusion criteria were
maintenance oral corticosteroids, an established diagnosis
of cardiac failure, PR within the last two years or exacer-
bation requiring hospitalisation within the last 6 weeks.
Patients qualifying for home long term oxygen therapy were
excluded.
Approval was obtained from the Leicestershire Research
Ethics Committee and all participants provided informed
written consent.
Study design
This was an observational study of patients participating in
the standard 7 week outpatient PR programme at University
Hospitals of Leicester NHS Trust.13 Spirometry was per-
formed to ERS standards (Vitallograph Model R, Bucking-
ham, UK) and predicted values calculated from ERS
regression equations.14 Body mass index (BMI) was calcu-
lated from height and weight. Outcome assessments were
made prior to commencing, and within 2 weeks of
completing PR. Disease specific health status was measured
using the Self Reported Chronic Respiratory Diseases
Questionnaire (CRQ-SR)15 (mean clinically important
difference for change with PR by 0.5 for each domain).
Maximal and sub-maximal field exercise capacity was
assessed before and after PR using the incremental (ISWT)16
and endurance (ESWT) shuttle walk tests respectively.17 All
patients completed a practice ISWT. In the ESWT patients
walked at a speed equivalent to 85% of predicted VO2max
from ISWT performance.
Pulmonary rehabilitation programme
Patients attended pulmonary rehabilitation at Glenfield-
Hospital, University Hospitals of Leicester NHS Trust, twice
weekly for a total of 14 sessions over at least 7 weeks. The
exercise component consisted of endurance (free walking)
and strength training with 1 h supervised exercise in each
session. For endurance exercise, patients walked at speed
equivalent to 85% peak VO2 predicted from baseline ISWT
performance. Patients were also asked to perform daily
home walking exercises. All patients walked at this speed
from the first session and walking times were then
increased progressively during the course of the pro-
gramme, with new targets set at each session. Patients also
underwent 5 min cycle exercise at each session. Cycle
resistance was increased as Borg breathlessness score
reduced. Strength training (biceps curls, sit to stand,
Exercise induced skeletal muscle metabolic stress 365pullups and stepups; 3 sets of eight repetitions) was per-
formed at each session. Hand weights started at 1 kg and
the weight was increased as perceived exertion fell.
Participants were able to rest between the endurance and
strength components of the exercise programme. The
education component consisted of 1 h each session and
covered a range of topics including disease education,
medication, diet, energy conservation, breathing control
and relaxation.
Laboratory exercise tests
On an initial visit familiarisation tests on a bicycle and
treadmill performed. At least 72 h later subjects performed
a maximal symptom-limited incremental exercise test on
an electrically-braked cycle ergometer. The workload was
increased by 10 W every minute using a ramp protocol to
determine peak exercise work capacity. Participants cycled
at a constant rate of 40e45 rpm and were encouraged to
continue cycling at the required rate for as long as possible.
Ventilation and gas exchange measurements were made
throughout the test using a breath-by-breath computerised
system (Zan-680 ErgoTest, Zan Messgeraete GmbH,
Germany). Participants were deemed ventilatory limited if
ventilation at peak exercise was greater than 90% predicted
MVV (calculated as FEV1  35).18
Blood analysis
Blood was sampled for ammonia and lactate concentration
at 1 min and 2 min of exercise, at peak exercise, and at
2 min following the incremental cycle exercise tests. During
the post-PR assessments an extra blood sample was taken
at the isotime of peak exercise achieved in the pre-PR
tests. Timing of blood sampling was based on previous
studies investigating the pattern of exercise ammonia
accumulation in COPD.7 Half an hour prior to the exercise
test a 12 g retrograde cannula was inserted into a superfi-
cial lower forearm vein and placed inside a hand-warmer,
warmed to 50e55 C. The hand-warmer enables arter-
ialised-venous blood to be collected, which is representa-
tive of arterial blood and is therefore not contaminated by
ammonia generated by the hand and forearm muscles. The
method used has been previously validated and used for
plasma ammonia measurements.19,20 Samples were imme-
diately placed on ice. Whole blood lactate concentrations
were measured in duplicate immediately following exercise
(YSI 1500 sport L-lactate analyser, YSI Inc, USA). Blood for
ammonia was centrifuged immediately following the exer-
cise test, plasma stored at 196 C in liquid nitrogen, and
analysed in duplicate by a validated enzyme assay tech-
nique (SigmaeAldrich Co. Ltd, UK) within 24 h as previously
described.7
Data analysis
Based on data from our previous study7 we required 22
patients to complete the study to detect a 15 mmol/l
within-group reduction in peak exercise blood ammonia
with PR (80% power, a Z 0.05). This difference represents
the upper threshold for the lack of ammonia rise duringexercise in our previous study7 and is also 95% confidence
interval for the reproducibility of repeat measures of
plasma ammonia at rest in healthy subjects recorded in our
laboratory (unpublished data). Subjects continued to be
recruited to the study until at least 22 had completed.
Subgroups were defined a priori by exercise-induced
ammonia rise during cycling above (group 1) or below
(group 2) 15 mmol/l. The response to rehabilitation was
assessed using ISWT and ESWT measurements as continuous
variables and categorically, defining a positive response to
PR as an increase in ISWT performance greater than 48 m.
This has been established as the minimum clinically
important difference for this outcome measure.21 Intra-
and inter-group differences were compared using the
paired and unpaired Students t-tests respectively. Corre-
lations between parameters were calculated using Pear-
son’s correlation (SPSS package version 15.0, SPSS Inc
Chicago, USA). Statistical significance was assumed at
p < 0.05.Results
Patient characteristics
A total of thirty-five patients were recruited and 25
patients (18/7 male/female, Mean (SD) age: 67 (8) years,
FEV1: 47 (18)% predicted, BMI: 28 (6) Kg/m
2, SaO2 at rest:
96 (2)%) completed the study. As this was an exploration of
the physiological adaptation to training, only completers
were analysed. The dropout rate is comparable to recent
published PR data from our clinical service.13,22 No differ-
ences between subjects who dropped out and completed
PR were identified in baseline demographic variables, field
or laboratory exercise performance or ammonia and lactate
response to exercise.
The response to pulmonary rehabilitation
Laboratory and field exercise performance increased after
PR (Table 1). Health status measured by CRQ-SR increased
significantly (p< 0.001) in all domains;mean (95%CI) changes
Dyspnoea 1.19 (0.68e1.70), Fatigue 0.89 (0.36e1.43),
Emotion 0.77 (0.10e1.45), Mastery 0.86 (0.18e1.53).
Metabolic response to exercise
In the whole cohort there was a significant exercise-
induced rise in plasma ammonia and blood lactate at
baseline. The lactate and ammonia response to exercise
before and after PR is shown in Table 2 and Fig. 1. Following
PR, exercise-induced ammonia accumulation was reduced
at all time points including peak exercise despite subjects
achieving higher peak exercise work rates. Exercise-
induced lactate accumulation was reduced at 1 and 2 min
and at isotime but not at peak exercise or 2 min recovery
after PR (Fig. 1). There were no differences between
patients who did or did not reach the a priori definition of
ventilatory limitation (during pre-PR exercise) in the
ammonia and lactate responses or in the improvement in
exercise capacity following PR.
Table 1 Mean (SD) exercise data from maximal cycling







Peak workload (W) 56 (21) e 69 (22)**
VO2 (ml/kg/min) 15.9 (4.8) 14.2 (4.8)** 17.2 (5.6)*
VE (L/min) 34.9 (11.8) 31.2 (8.8)* 38.4 (12.6)**
VE (% MVV) 86 (19) 78 (17)** 95 (19)**
RER 0.96 (0.05) 0.93 (0.04) 0.96 (0.05)
ISWT (m) 287 (128) e 380 (141)**
ESWT (s) 176 (53) e 678 (374)**
WR Z Work rate; VO2 Z oxygen uptake; VE Z Exercise venti-
lation; RER Z respiratory exchange ratio; MVV Z maximum
voluntary ventilation (calculated as FEV1  35).
ISWT Z Incremental shuttle walk test; ESWT Z endurance
shuttle walk test.
Comparison between pre-PR and post-PR values: *p < 0.05,
**p < 0.01.
a Time point during post-PR exercise test at which peak
exercise was reached in pre-PR test.
Figure 1 Change in plasma ammonia (upper panel) and blood
lactate (lower panel) from resting values during maximal
cycling exercise before (solid lines) and after (dashed lines)
Pulmonary Rehabilitation (PR). *p < 0.05, **p < 0.001 between
pre-PR and post-PR analysis.
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Using our predetermined criteria for a significant ammonia
response to exercise at baseline, there were 18 subjects in
Group 1 (subjects with a significant exercise-induced
ammonia response) and 7 in Group 2 (subjects without
a significant exercise-induced ammonia response). There
was no statistically significant difference between these
subgroups in demographics or disease severity at baseline.
Exercise performance at baseline was lower in group 2 but
this was not statistically significant (Table 3). There was no
significant difference between the groups in oxygen satu-
ration at rest or at peak exercise or in the number of
subjects deemed ventilatory limited during the initial
incremental exercise test.
There was no significant difference between the
subgroups in the change in field or laboratory exercise
performance after PR. Measurements of plasma ammonia
and blood lactate during exercise at baseline and after PR
are shown in Table 4 and Fig. 2. In Group 1 ammonia
accumulation was lower after PR at all time points (Fig. 2).
In group 2 the lack of ammonia response to exercise was
unchanged following PR, although there was a trend
towards increased ammonia accumulation at peak exerciseTable 2 Plasma ammonia and blood lactate concentrations at r
Concentrations expressed as mean (SD) and change as mean (SEM
Rest Isotime peak
exercisea
Ammonia conc mmol/l Pre-PR 53.3 (13.4) e
Post-PR 53.1 (12.4) 63.8(11.4)**
Lactate conc mmol/l Pre-PR 0.74 (0.16) e
Post-PR 0.66 (0.13)* 1.33(0.64)**
*p < 0.05, **p < 0.001 between pre-PR and post-PR.
a Time point during post-PR exercise test at which peak exercise w
b Calculated as maximum ammonia concentration (at any time poinpost-PR (p Z 0.079). Lactate accumulation in both groups
was attenuated by PR at all time points except when
comparing peak exercise lactate concentrations (Fig. 2).
Two subjects in group 1 did not subsequently demonstrate
an ammonia response following PR whereas one subject in
group 2 did subsequently have a significant ammonia rise
with exercise after PR.
Relationships between ammonia and lactate
response and the outcome of PR
Complete data for the change in ISWT following PR was








82.3 (21.0) 77.3 (25.0) 33.0 (4.7)
73.3 (13.6)* 73.0 (15.3)* 24.0 (2.8)*
1.90 (0.71) 2.07 (0.82) 1.42 (0.14)
1.82 (0.88) 2.10 (1.00) 1.46 (0.19)
as reached in pre-PR test.
t) minus resting concentration.
Table 3 Baseline characteristics for COPD subjects for subgroup analysis (Group 1: subjects with baselinemax exercise-induced
change in ammonia> 15 mmol/l; Group 2: subjects with baseline max exercise induced change in ammonia<15 mmol/l). Absolute
values expressed as mean (SD). Change expressed as mean (SEM).
Group 1 (n Z 18) Group 2 (n Z 7)
Pre-PR Change with PR Pre-PR Change with PR
Age (years) 67 (7) e 68 (10) e
FEV1 (% predicted) 48 (19) e 46 (15) e
BMI (kg/m2) 27.7 (6.4) 27.9 (7.2)
O2 saturation at rest (%) 96 (2) e 96 (1) e
ISWT distance (m) 309 (128) 97 (19) 203 (113) 82 (23)
ESWT time (s) 118 (57) 531 (89) 158 (46) 417 (143)
Peak workload (W) 61 (22) 14 (3) 43 (14) 11 (3)
VO2max (ml/kg/min) 16.4 (5.1) 1.36(0.50) 14.2 (3.2) 1.29(0.96)
Peak VE (L) 37.3 (12.7) 3.9 (4.5) 28.6 (5.7) 2.6 (4.8)
Peak VE (% MVV) 87 (19) 9.4(8.2) 84 (22) 7.3(14.8)
Exercise induced skeletal muscle metabolic stress 367of >48 m in ISWT performance. There was no statistically
significant difference in the ammonia or lactate response at
baseline or the change in the ammonia/lactate response
resulting from PR between patients who did or did not
achieve the threshold of a 48 m improvement in ISWT
performance (Table 5).
The exercise ammonia and lactate responses at baseline
showed no significant correlation with changes in physical
performance (Peak WR, VO2max or ISWT) when expressed
as continuous variables for all COPD patients or for either
subgroup of patients. There was a negative correlation
between the change in maximum exercise-induced lactate
accumulation resulting from PR and the improvement in
peak exercise WR (rZ 0.42, pZ 0.036). Otherwise there
were no other correlations between changes in the
ammonia/lactate responses to exercise and changes in
physical performance (expressed as continuous variables)
after PR.Discussion
We have described the effects of a pragmatic, semi-
supervised outpatient pulmonary rehabilitation programme
on the skeletal muscle metabolic response to exercise. OurTable 4 Mean values for ammonia and lactate with isotime and
subjects with baseline max exercise-induced change in ammonia
induced change in ammonia <15 mmol/l). Figures in parenthesis
induced changes.







Pre-PR 51.4 (12.7) e 3
Post-PR 51.5 (10.2) 12.7 (2.0) 2
Blood lactate
(mmol/l)
Pre-PR 0.76 (0.15) e 1
Post-PR 0.65 (0.13) 0.73 (0.15) 1
*p < 0.05, **p < 0.01. Between group comparison; group 1 vs group 2
a Change over resting values at the same time point during post-PR
b Change over resting values at peak exercise.data suggest a reduction in exercise-induced metabolic
stress following PR despite higher peak work rates ach-
ieved, as evidenced by reduced blood ammonia and lactate
accumulation. However, contrary to our initial hypothesis,
the subgroup of patients without an exercise-induced
ammonia response showed similar improvements in exer-
cise capacity following PR, and the functional outcome of
PR could not be predicted from the baseline exercise
ammonia response.
Improving physical performance is an important thera-
peutic goal in COPD and impaired skeletal muscle metabolic
function is a modifiable factor contributing to exercise
intolerance in this population. The current study is the first
to report the effects of PR on metabolic stress (as measured
by plasma ammonia levels) during exercise in COPD.
Previous studies in healthy subjects have suggested
a similar effect of aerobic training on the ammonia
response.23,24 The reduction in plasma ammonia accumu-
lation in COPD patients following PR suggests a reduction in
adenine nucleotide loss due to better cellular ATP delivery
in response to the demands of exercise. The precise
mechanisms for these observations cannot be determined
directly as we did not obtain muscle biopsies during exer-
cise in this study. However, the concomitant reduction in
lactate accumulation suggests that this is mediated throughpeak exercise-induced changes in COPD subgroups (Group 1:
> 15 mmol/l; Group 2: subjects with baseline max exercise-
refer to SD for absolute values at rest and SEM for exercise-







9.7 (3.9) 58.2 (14.9) e 1.5 (1.4)**
4.1 (2.6) 57.2 (17.0) 5.3 (2.5)* 10.2 (4.0) **
.26 (0.18) 0.68 (0.18) e 0.91 (0.17)
.30 (0.21) 0.68 (0.14) 0.51 (0.16) 0.80 (0.22)
.
exercise test at which peak exercise was reached in pre-PR test.
Figure 2 AeD: Subgroup comparison of COPD subjects with and without an ammonia rise on pre-PR cycling exercise. Change in
plasma ammonia and blood lactate from resting values during maximal cycling exercise in group 1 (nZ 18) (A and C) and group 2
(n Z 7) (B and D). Pre-PR data is depicted in solid lines and post-PR data in dashed lines. Group 1: subjects with baseline max
exercise-induced change in ammonia >15 mmol/l; Group 2: subjects with baseline max exercise-induced change in ammonia
<15 mmol/l **p < 0.001, *p < 0.05 between pre-PR and post-PR analysis.
368 L.D. Calvert et al.a reduction in anaerobic energy delivery resulting from an
increase in mitochondrial (oxidative) capacity. This is in
keeping with previous studies which have demonstrated
increases in mitochondrial oxidative enzyme concentra-
tions from muscle biopsies,10 reduced blood lactate accu-
mulation11 and improved rates of phosphocreatine
resynthesis following aerobic training in COPD.3 Alternative
explanations could be a shift in the relative sizes of type I
and II fibres towards a greater proportion of type I fibres
following PR or an improvement in oxygen delivery to theTable 5 Mean (SEM) changes in the ammonia and lactate respon
with and without a clinically significant increase in ISWT perform
Change in ammonia at peak exercise pre-PR (mmol/l)
Maximum exercise induced change in ammonia Pre PR (mmol/l)b
Change in lactate at peak exercise pre-PR (mmol/l)
Maximum exercise-induced change in lactate Pre PR (mmol/l)b
Change in ammonia response at isotime after PR (PreePost-PR) (
Change in Maximum exercise-induced ammonia rise after PR (Pre
Change in lactate response at isotime after PR (PreePost) (mmol
Change in maximum exercise-induced lactate rise after PR (Pree
a Time point during post-PR exercise test at which peak exercise w
b Peak change is calculated as peak ammonia/lactate concentrationambulatory muscles through central cardiopulmonary
adaptations to physical training.
We had hypothesized that the functional response to
rehabilitation would be reduced in Group 2 (no exercise-
induced ammonia rise) because of insufficient muscle
overload during training, but in fact we found that
improvements in field and laboratory exercise capacity
were of similar magnitude to Group 1 and there was no
correlation between the ammonia or lactate response to
exercise at baseline and the functional outcome of PR. Oneses to maximal cycling exercise before and after PR in patients





33.5 (6.4) 24.8 (5.7)
37.4 (6.6) 29.3 (26.2)
1.26 (0.21) 0.98 (0.16)
1.52 (0.80) 1.26 (0.19)
mmol/l)a 20.8 (5.94) 16.9 (4.39)
ePost) (mmol/l)b 7.3 (5.9) 13.1 (5.5)
/l)a 0.46 (0.12) 0.51 (0.13)
Post PR) (mmol/l)b 0.24 (0.23) 0.21 (0.11)
as reached in pre-PR test.
(measured at any time point) minus resting concentration.
Exercise induced skeletal muscle metabolic stress 369possibility is that patients in this subgroup were too
disabled to exercise intensively enough to provoke meta-
bolic stress because of ventilatory limitation. There was no
difference between the groups in maximum exercise
ventilation and no difference in the metabolic response to
exercise between patients with and without ventilatory
limitation, although we acknowledge we have not
measured exercise-related dynamic hyperinflation.
Patients in group 2 showed a significant rise in blood lactate
in the absence of an ammonia response suggesting that the
intensity of exercise was substantial, although we recognise
that we do not have detailed session to session data on
training workloads. We speculate that in these individuals,
despite the mobilisation of non-oxidative sources of energy,
ATP resynthesis was sufficient to meet the demands of
muscular work (presumably because of better preservation
of mitochondrial sources of ATP). The reasons for this
cannot be determined from this study but could reside in
the fibre characteristics of the lower limb muscles in this
group. Previous studies have suggested a shift in fibre
composition towards a greater proportion of Type II fibres in
COPD.25 Type II fibres are more susceptible to adenine
nucleotide loss and ammonia production26 and therefore
Group 2 patients could represent those with better pres-
ervation of Type I fibre numbers and/or size.
We acknowledge a number of limitations to the inter-
pretation of the data in this study. Blood measurements
may not always reflect intramuscular events. However,
previous studies have confirmed the relationship between
blood ammonia accumulation and adenine nucleotide loss
in healthy subjects6,27 and we have done so ourselves
previously in COPD patients.7 Our threshold for a significant
rise in ammonia is inevitably arbitrary but was determined
rationally from the variation of repeated measurements of
ammonia in our laboratory and our previous studies which
showed clear separation of the groups at this level.7,8 The
numbers in each subgroup were relatively small and
therefore statistical comparisons may be subject to type II
error. We acknowledge that our observations have been
restricted to maximal cycling exercise and would need to
be confirmed for other exercise modes or platforms such as
constant load exercise or walking performance. Similarly,
we recognise our data may not be generalisable to the
wider COPD population, for example those with milder
disease.
The clinical benefits of pulmonary rehabilitation are well
established and the intervention is enshrined in national
and international guidelines for the management of
COPD.9,28,29 Previous studies in controlled laboratory
settings have indicated that skeletal muscle adaptations
occur in response to aerobic training.10,11 In the current
study, we have confirmed that substantial improvements in
skeletal muscle ATP delivery can be brought about by
a pragmatic semi-supervised outpatient rehabilitation pro-
gramme incorporating high intensity walking exercise. Our
observation that the clinical outcome of rehabilitation
could not be predicted from these adaptations or the
baseline physiological response highlights the complex,
mixed mechanisms underpinning the benefits of PR,
including behavioural factors such as motivation and mood.
For example many patients may be able to utilise more of
their pre-existing physical capacity after rehabilitationthrough improvements in confidence and self-efficacy
rather than through physiological adaptation. Predicting
the outcome of PR from baseline disease, demographic and
physiological variables has proved difficult and as a result
inclusion criteria for PR remain broad.9 The current study
highlights this issue and also suggests that physiological
adaptation during training itself may not identify those with
a favourable clinical response. However, further under-
standing of the mechanisms underpinning metabolic adap-
tation to PR is essential if we are to individualise and
augment therapy in the future.
In summary, we have demonstrated that a pragmatic
outpatient PR programme results in significant adaptation
to the metabolic response to exercise. However, the clin-
ical response to rehabilitation could not be predicted from
the baseline exercise response highlighting the heteroge-
neous mechanisms that underpin clinical outcomes in
pulmonary rehabilitation.Funding
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